Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

NXTM Insider Trading

NXTM | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at NXTM provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2010-08-11 02:29 2010-08-06 CHAMBON PHILIPPE Director SELL $16.12 78,100 $1,259,277 6,028,833 -1.3%
2010-08-10 02:53 2010-08-06 CREDIT SUISSE AG/ 10% owner SELL $16.03 33,400 $535,405 6,325,222 -0.5%
2010-08-07 00:45 2010-08-05 CREDIT SUISSE AG/ 10% owner SELL $16.36 37,100 $606,897 6,358,622 -0.6%
2010-08-06 02:03 2010-08-03 CREDIT SUISSE AG/ 10% owner SELL $16.35 400,000 $6,539,320 6,395,722 -5.9%
2010-08-06 01:17 2010-08-03 CHAMBON PHILIPPE Director SELL $16.32 437,100 $7,134,302 6,106,933 -6.7%
2010-08-05 02:04 2010-08-02 ORBIMED ADVISORS LLC Director, 10% owner SELL $16.38 317,700 $5,203,259 4,700,000 -6.3%
2010-08-04 01:46 2010-07-30 CREDIT SUISSE AG/ 10% owner SELL $16.09 28,800 $463,392 6,795,722 -0.4%
2010-08-04 02:24 2010-07-30 CHAMBON PHILIPPE Director SELL $16.09 28,800 $463,507 654,033 -4.2%
2010-07-30 17:05 2010-07-27 CREDIT SUISSE AG/ 10% owner SELL $16.83 383,473 $6,454,502 6,824,522 -5.3%
2010-07-30 00:21 2010-07-28 Utterberg David S Director, 10% owner SELL $15.84 715,000 $11,322,883 6,894,276 -9.4%
2010-07-29 23:32 2010-07-27 MOORE CRAIG W Director OPT+S $16.89 8,945 $151,081 46,905 0.0%
2010-07-30 04:57 2010-07-27 CHAMBON PHILIPPE Director SELL $16.83 383,473 $6,454,502 6,572,833 -5.5%
2010-07-29 23:28 2010-07-27 REID PERPER Director OPT+S $16.89 8,945 $151,081 194,023 0.0%
2010-07-30 01:40 2010-07-27 ORBIMED ADVISORS LLC Director, 10% owner SELL $16.88 700,556 $11,823,284 5,017,700 -12.3%
2010-07-19 23:29 2010-07-19 Shea Thomas Officer - SVP Manufacturing Operations OPT+S $13.99 2,000 $27,980 48,310 0.0%
2010-07-16 01:01 2010-07-15 Brown Robert S. Officer - Sr. Vice President, CFO OPT+S $14.08 5,000 $70,400 72,784 0.0%
2010-07-16 00:59 2010-07-14 Burbank Jeffrey H Director, Officer - President & CEO SELL $14.32 13,000 $186,105 634,906 -2.0%
2010-07-13 00:45 2010-07-12 Swan Winifred L Officer - SVP and General Counsel SELL $14.50 3,107 $45,052 80,533 -3.7%
2010-07-09 13:11 2010-07-07 Turk Joseph E Jr Officer - SVP Commercial Operations SELL $14.01 2,000 $28,020 169,725 -1.2%
2010-06-23 23:16 2010-06-22 Turk Joseph E Jr Officer - SVP Commercial Operations SELL $13.92 2,000 $27,840 171,725 -1.2%
2010-06-18 01:44 2010-06-17 Brown Robert S. Officer - Sr. Vice President, CFO OPT+S $13.88 5,000 $69,400 75,784 0.0%
2010-06-18 01:43 2010-06-17 Shea Thomas Officer - SVP Manufacturing Operations OPT+S $13.88 2,000 $27,760 49,310 0.0%
2010-06-18 01:40 2010-06-15 Swan Winifred L Officer - SVP and General Counsel SELL $13.81 3,107 $42,908 83,640 -3.6%
2010-06-18 01:38 2010-06-16 Burbank Jeffrey H Director, Officer - President & CEO SELL $13.82 13,000 $179,605 647,906 -2.0%
2010-05-22 01:24 2010-05-20 Brown Robert S. Officer - Sr. Vice President, CFO OPT+S $11.97 5,000 $59,850 78,784 0.0%
2010-05-20 02:17 2010-05-17 Utterberg David S Director, 10% owner SELL $13.15 826,033 $10,864,564 7,609,276 -9.8%
2010-05-20 02:14 2010-05-18 Turk Joseph E Jr Officer - SVP Commercial Operations SELL $13.53 2,000 $27,060 173,725 -1.1%
2010-05-20 02:10 2010-05-17 Shea Thomas Officer - SVP Manufacturing Operations OPT+S $14.06 2,000 $28,120 50,310 0.0%
2010-05-20 02:07 2010-05-18 Swan Winifred L Officer - SVP and General Counsel SELL $13.53 3,107 $42,038 86,747 -3.5%
2010-05-20 02:05 2010-05-19 Burbank Jeffrey H Director, Officer - President & CEO SELL $12.70 13,000 $165,131 660,906 -1.9%
2010-03-19 00:23 2010-03-16 Utterberg David S Director, 10% owner SELL $10.56 50,000 $528,100 8,435,309 -0.6%
2010-03-19 00:21 2010-03-16 Turk Joseph E Jr Officer - SVP Commercial Operations SELL $10.52 4,800 $50,487 175,725 -2.7%
2010-03-11 00:45 2010-03-08 Webb Michael J. Officer - SVP, Quality & Regulatory OPT+S $9.91 77,283 $765,805 58,877 0.0%
2010-03-04 03:38 2010-03-01 Swan Winifred L Officer - SVP and General Counsel OPT+S $10.63 29,211 $310,557 22,430 0.0%
2009-12-17 00:08 2009-12-11 Flynn James E 10% owner SELL $7.30 10,288 $75,102 1,351,674 -0.8%
2009-12-16 03:09 2009-12-11 Flynn James E 10% owner SELL $8.23 102,388 $842,377 1,292,874 -7.3%
2009-12-11 02:12 2009-12-08 Flynn James E 10% owner SELL $7.37 54,546 $401,960 1,358,239 -3.9%
2009-12-08 04:58 2009-12-03 Flynn James E 10% owner SELL $7.42 206,228 $1,530,851 1,393,036 -12.9%
2009-10-14 01:18 2009-10-09 Flynn James E 10% owner SELL $6.74 11,602 $78,175 1,524,611 -0.8%
2009-10-02 00:47 2009-09-29 Flynn James E 10% owner SELL $7.07 3,669 $25,940 1,532,015 -0.2%
2009-09-24 01:26 2009-09-21 Flynn James E 10% owner SELL $6.74 34,161 $230,122 1,534,356 -2.2%
2009-09-22 00:33 2009-09-17 Flynn James E 10% owner SELL $6.73 68,460 $461,044 1,556,151 -4.2%
2009-09-17 00:17 2009-09-11 Flynn James E 10% owner SELL $6.84 226,638 $1,549,751 1,599,829 -12.4%
2009-06-19 23:16 2009-06-12 Flynn James E 10% owner SELL $5.96 27,078 $161,385 1,771,770 -1.5%
2008-08-29 00:06 2008-08-26 ORBIMED ADVISORS LLC Director, 10% owner BUY $3.50 27,700 $97,052 5,718,256 +0.5%
2008-08-26 01:15 2008-08-21 ORBIMED ADVISORS LLC Director, 10% owner BUY $3.35 135,000 $451,940 5,690,556 +2.4%
2008-08-23 00:46 2008-08-21 PHILDIUS PETER P Director SELL $3.28 13,570 $44,511 3,642 -78.8%
2008-08-15 23:05 2008-08-13 PHILDIUS PETER P Director SELL $4.03 6,500 $26,208 17,212 -27.4%
2008-08-14 00:35 2008-08-11 PHILDIUS PETER P Director OPT+S $4.21 12,100 $50,953 23,712 0.0%
2008-08-14 00:38 2008-08-12 MOORE CRAIG W Director BUY $4.00 10,000 $40,000 28,421 +54.3%
SHOW ENTRIES

How to Interpret $NXTM Trades

Not every insider transaction in NXTM is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $NXTM shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for NXTM

Insider activity data for NXTM is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $NXTM, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.